Elevated extracellular lactate, a defining feature of the tumor microenvironment, predicts poor outcomes, and high GPR81 expression correlates with poorer survival (8,53,54)
Peptide clears from blood BUT cellular processes continue Duration of cellular effects: Why this matters: Don't need continuous high levels in blood Single injection triggers multi-day effects 2-3x weekly dosing sufficient (not daily required) Cellular "memory" of GHK-Cu exposure Cumulative effects with repeated dosing: Each dose builds on previous Collagen accumulation over weeks Tissue remodeling compounds Results improve with consistent use Comparing GHK-Cu to other peptides Half-life comparison table: GHK-Cu positioning: Short half-life like Ipamorelin But longer cellular effects than half-life suggests Middle-ground dosing frequency (not daily, not weekly) Cumulative benefits with consistency See our BPC-157 guide , TB-500 guide , peptide dosing guide , and peptide dosage chart
Chen L, Chen S, Rong Y, et al
Treatments are delivered by licensed nurses under medical direction using pharmaceutical-grade formulations
They respect the old timers in the industry